【レポートの概要（一部）】
1. Report Overview
1.1 Global Drug Delivery Technologies Market Overview
1.2 Global Drug Delivery Technologies Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction to Drug Delivery
2.1 Drug Delivery Technologies (DDT)
2.2 Drug Delivery Technologies – Types
2.2.1 Injection As a Route of Drug Delivery
2.2.2 Needle-free Transdermal Delivery
2.2.3 Oral Delivery Technologies
2.2.4 Inhalation or Spray
2.3 Sustained/Controlled Release Systems
2.4 Biopharmaceuticals
2.4.1 An introduction to the Biologic Drugs Market
2.4.2 Biologics: A Rising Drugs Market
2.4.3 Biotech Drugs with Associated Drug Delivery Technologies
2.4.4 Pegylated Interferons
2.4.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
2.4.6 The Main Challenges Facing Biological Drug Delivery
2.5 Market Definition
3. The Global Drug Delivery Technologies Market, 2014-2024
3.1 Global Drug Delivery Technologies: Market Overview
3.1.1 Drug Delivery Technologies: A Growing Market
3.2 The Global Drug Delivery Technologies Market in 2013
3.2.1 Global Drug Delivery Technologies: Market Forecast 2014-2024
3.2.2 Changing Market Shares by Sector 2014-2024
3.3 Oral Drug Delivery Technologies Market 2014-2024
3.3.1 Oral Drug Delivery Technologies: Market Forecast 2014-2024
3.4 Inhalation Drug Delivery Technologies Market 2014-2024
3.4.1 Inhalation Drug Delivery Technologies: Market Forecast 2014-2024
3.5 Injectable/Implants Drug Delivery Technologies Market 2014-2024
3.5.1 Injectable/Implants Drug Delivery Technologies: Market Forecast 2014-2024
3.6 Transdermal Drug Delivery Technologies Market 2014-2024
3.6.1 Transdermal Drug Delivery Technologies: Market Forecast 2014-2024
3.7 Ocular Drug Delivery Technologies Market 2014-2024
3.7.1 Ocular Drug Delivery Technologies: Market Forecast 2014-2024
3.8 Nasal Drug Delivery Technologies Market 2014-2024
3.8.1 Nasal Drug Delivery Technologies: Market Forecast 2014-2024
4. Leading National Markets 2014-2024
4.1 The Drug Delivery Technologies Market by Regional Revenue
4.1.1 The Global Distribution of Drug Delivery Technologies in 2013
4.2 Leading National Markets: Forecast, 2014-2024
4.2.1 Changing Market Shares by Region, 2014-2024
4.3 Regional Drug Delivery Technologies Markets: Analysis and Forecasts, 2014-2024
4.3.1 United States: The Largest Market for Drug Delivery Technologies
4.3.2 The EU5 Markets:
4.3.2.1 EU5: Changing Market Shares by Country, 2014-2024
4.3.2.2 Germany: Fiscal Austerity Programs and Spending Cuts
4.3.2.3 France: Strong Drug Discovery Landscape
4.3.2.4 UK: An Increasingly Service-Oriented Market
4.3.2.5 Spain: Recovering Economy to Stimulate Healthcare Investment
4.3.2.6 Italy: Changing Reimbursement Culture Will Aid Market Growth
4.3.3 Japan: Aging Population Stimulating Drug Demand
4.3.4 China: Intensive Talent Resource and Relative Low Cost
4.3.5 India: A Hotbed For Drug Delivery Technology Manufacturing and Outsourcing
4.3.6 Brazil: Government Subsidies Boosting Drug Production
4.3.7 Russia: Availability of Custom Libraries for Drug Molecules Will Catalyse Growth
4.3.8 South Korea: Acquisition of Promising Overseas Companies Will Aid Market Growth
4.3.9 Mexico: Government Initiatives and Regulatory Changes Boosting Market Growth
4.3.10 Rest of the World
5. Leading Drug Classes Offering Growth for Drug Delivery Technologies
5.1 Therapeutic Areas Offering Growth Opportunities
5.2 Biologics: A Future Driver for Growth in Drug Delivery Technologies
5.2.1 Leading Classes of Biological Drugs, 2013
5.3 Monoclonal Antibodies: Largest Sector in Biologics
5.3.1 Monoclonal Antibodies: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.4 Human Insulins
5.4.1 Insulins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.4.2 Exubera: An Alternative Delivery Method for Biological Drugs
5.4.2.1 The First Inhaled Insulin
5.4.2.2 A History of Exubera: Development and Post-Marketing
5.4.3 Generex and MannKind Developing Next-Generation Oral Insulins
5.4.4 Challenges Facing Oral-lyn and Afrezza
5.5 Interferons
5.5.1 Interferons: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.6 Erythropoietin Products
5.6.1 Erythropoietins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.7 Granular-Colony Stimulating Factors (G-CSF)
5.7.1 Granular-Colony Stimulating Factors (G-CSF): Prospects, Forecast, and Implications for Drug Delivery Technologies
5.8 Recombinant Coagulation Factors
5.8.1 Recombinant Coagulation Factors: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.9 Other Therapeutic Proteins
5.9.1 Other therapeutic Proteins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.10 The Biosimilars Market in 2013
5.10.1 Biosimilars: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.11 The Vaccines Market in 2013
5.11.1 Vaccines: Market Forecast 2014-2024
5.12 The Role of Biologics in the Drug Delivery Technologies Market
6. Leading Companies in the Drug Delivery Technologies Market, 2014
6.1 Drug Delivery Technologies: A Fragmented Market
6.2 Leading Companies in Inhaled Drug Delivery Technologies
6.2.1 3M: A Global Health Information Systems Provider
6.2.1.1 3M Healthcare Revenue Analysis, 2013
6.2.1.2 3M’s Drug Delivery Technologies
6.2.1.2.1 Protein and Peptide Delivery
6.2.1.2.2 Excipient Technology for CFC-Free Inhalers
6.2.1.2.3 Actuator Technology for Metered Dose Inhalers
6.2.1.2.4 Particle Engineering Technology
6.2.2 Aradigm Corporation
6.2.2.1 AERx Drug Delivery System
6.2.2.2 Aradigm’s Partnerships
6.2.2.3 Aradigm’s Pipeline Products
6.2.3 Vectura Group
6.2.3.1 Vectura’s Technologies and Products
6.2.3.2 Vectura’s Development Pipeline
6.3 Leading Companies in Oral Drug Delivery Technologies
6.3.1 Applied Pharma Research (APR)
6.3.1.1 APR’s Technology and Product Offerings
6.3.2 Catalent Pharma
6.3.2.1 Catalent’s Drug Delivery Technologies
6.3.2.2 Catalent Revenue Analysis, 2009-2013
6.3.2.3 Catalent’s Recent Activities
6.3.3 Emisphere Technologies
6.3.3.1 Emisphere’s Eligen Technology
6.3.3.2 Emisphere Revenue Analysis, 2010-2013
6.3.3.3 Emisphere: Pipeline Products
6.3.4 Ethypharm
6.3.4.1 Ethypharm’s Drug Delivery Technologies
6.3.4.2 Ethypharm’s Currently Marketed Products
6.3.5 Glycologic
6.3.5.1 Glycologic’s Drug Delivery Technologies
6.3.5.2 Glycologic’s Pipeline Developments
6.4 Leading Companies in Injectable Drug Delivery Technologies
6.4.1 Alkermes
6.4.1.1 Alkerme’s Drug Delivery Technologies
6.4.1.2 Alkermes Revenue Analysis, 2009-2013
6.4.1.3 Alkerme’s Product Pipeline
6.4.2 Pacira Pharmaceuticals
6.4.2.1 Pacira’s Injectable Sustained–Release Technologies
6.4.2.2 Pacira Pharmaceuticals: Revenue Analysis, 2009-2013
6.5 Leading Companies in Transdermal Drug Delivery Technologies
6.5.1 Nanopass Technologies
6.5.1.1 Nanopass Drug Delivery Products
6.5.1.1.1 Anti-aging Microdermabrasion
6.5.1.1.2 Microjet Needle
6.5.2 Noven Pharmaceuticals
6.5.2.1 Noven Pharmaceuticals’ Transdermal Products
6.5.2.2 Noven’s Development Pipeline
6.6 Leading Companies for Transmucosal Drug Delivery
6.6.1 CIMA Labs
6.6.1.1 CIMA’s Transmucosal Drug Delivery Technologies
6.6.1.2 The OTS System
6.6.1.3 OraVescent Technology
6.6.2 Columbia Laboratories
6.6.2.1 Columbia Labs’ Bioadhesive Delivery Technology
6.6.2.2 Columbia Labs’ Products
6.6.2.3 Columbia Labs Revenue Analysis, 2009-2013
6.6.3 Generex Biotechnology Corporation
6.6.3.1 Generex’s Products
6.6.3.2 Generex: Revenue Analysis, 2011-2013
6.7 Leading Implantable Drug Delivery Technology Companies
6.7.1 pSivida Corporation
6.7.1.1 pSivida’s Drug Delivery Technologies
6.7.1.1.1 Durasert Technology
6.7.1.1.2 Tethadur Technology
6.7.2 pSivida Products
7. Qualitative Analysis of the Drug Delivery Technologies Market 2014-2024
7.1 SWOT Analysis of the Drug Delivery Technologies Market, 2014-2024
7.2 Strengths
7.2.1 Biosimilars: Legislations Encouraging Innovation
7.2.2 Patent Expiries and the Resulting Increase in Competition Will Favour Drug Delivery Technologies
7.2.3 Monoclonal Antibodies Will Drive Delivery Technologies
7.2.4 PEGylation Assisting Growth
7.3 Weaknesses
7.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult
7.4 Opportunities
7.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery
7.4.2 Possible New Delivery Methods for Insulin
7.4.3 Availability of Cost effective Solutions Will Stimulate Uptake of Drug Delivery Technologies
7.5 Threats
7.5.1 The Conservative Mindset of Drug Developers May Hinder Innovation in Drug Delivery
7.5.2 The Current Limit on Feasible Route of Administration for Biotech Drugs May Limit Drug Delivery Growth
7.5.3 Lifecycle Management via Protein Engineering Blurs Drug Delivery Lines
8. Expert Opinions
8.1 Interview with Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark
8.1.1 On the Current State of Drug Delivery Technologies
8.1.2 The ‘Magic Bullet’ – A Challenge for Innovation
8.1.3 Self-Assembling Protein Systems and the Use of Nanostructures for Drug Targeting
8.1.4 Technological Developments in Drug Development – Quantum Dots, Silicon Structures, and Polymeric Materials
8.1.5 On Future Challenges and Opportunities
8.2 Interview with Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
8.2.1 The Need for Novel Delivery Mechanisms Driving Growth
8.2.2 Therapeutic Areas That Are Propelling Drug Delivery Technologies
8.2.3 Drug Delivery Barriers and the Need for Targeting
8.2.4 Advancements in Drug Delivery in the Coming Years
8.2.5 Future Challenges for Drug Delivery Technologies
8.2.6 Future Opportunities for Drug Delivery Technologies
9. Conclusion
9.1 Market Overview
9.2 Commercial Drivers for Drug Delivery Technology
9.3 Transdermal Drug Delivery Technologies Set For High Growth
9.4 Biologics Will Drive Market Growth
9.5 Leading Companies in the Drug Delivery Technologies Market
9.6 Growth Concentrated in Developed Markets and in the Innovative Markets of South America and South Asia
9.7 Future Prospects for Drug Delivery Technologies
【レポート販売概要】
■ タイトル：ドラッグデリバリー技術市場（2014-2024）■ 英文：Drug Delivery Technologies Market Forecast 2014-2024
■ 発行日：2014年4月
■ 調査会社：visiongain
■ 商品コード：Visiongain-405315
■ 調査対象地域：グローバル
- PMMAの世界市場2017-2021About PMMA PMMA is a synthetic resin produced by the polymerization of methyl methacrylate. It is a clear acrylic material that is replacing glass products. PMMA is a linear thermoplastic polymer that possesses high mechanical strength and is scratch resistant. Technavio’s analysts forecast the global PMMA market to grow at a CAGR of 4.94% during the period 2017-2021. [Covered in this report] The …
- 導電性インクの世界市場：銀フレーク、誘電性インク、銀ナノ粒子、銅フレーク、炭素ナノ粒子、炭素/グラフェン、導電性ポリマThe global market size of conductive inks is projected to reach USD 3.91 Billion by 2021, registering a CAGR of 3.5% between 2016 and 2021. The growing solar industry in all the regions is expected to majorly drive the conductive inks market during the forecast period. The wide application in solar panels, automotive circuits, and electronic & electrical equipment is also expected to drive the glo …
- ベビーフード及び飲料の世界市場：ミルク、乾燥ベビーフード、調理済み食品The baby food industry is one of the fastest growing segments in the global food market. We forecast the global baby food and drink market will reach a value $55.05bn in 2015. Once the fastest growing segment in the developed markets of North America and Europe, today, the industry is booming in Asia-Pacific, MEA and Latin America. This has been significantly prompted by the growing number of wome …
- 世界の織物用ガラス繊維市場2015The Global Textile Glass Fibers Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Textile Glass Fibers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Textile Glass Fibers market analysis is provided for the international markets including develop …
- Cataract Surgery Devices Market to 2019 – Advanced Intraocular Lenses (IOLs) and a Growing Patient Population in Emerging Countries Offer Significant Growth PotentialCataract Surgery Devices Market to 2019 - Advanced Intraocular Lenses (IOLs) and a Growing Patient Population in Emerging Countries Offer Significant Growth Potential Summary GBI Research’s report, “Cataract Surgery Devices Market to 2019 - Advanced Intraocular Lenses (IOLs) and a Growing Patient Population in Emerging Countries Offer Significant Growth Potential" looks at the market, competitive …
- 多発性骨髄腫治療薬の世界市場About Multiple Myeloma Multiple myeloma is a common cancer that affects the plasma cells, a type of white blood cell. It begins in the plasma cells of bone marrow. The primary function of the plasma cells is to combat infections by producing antibodies, which attack germs after recognizing them. In multiple myeloma these plasma cells become malignant, it causes the production of a defective protei …
- 道路安全ソリューションの世界市場予測（～2020）MarketsandMarkets forecast the road safety market size to grow from USD 2.35 Billion in 2015 to USD 3.63 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.1%. With the increase in the number of passenger traffic and congestion on the roads, the demand for technology-driven, automated, and a highly secured road infrastructure has grown immensely. The major factors contributing to the gr …
- 貨物輸送の世界市場：液体貨物、バラ積み乾貨物、一般貨物、コンテナー貨物In the past decade it has been seen that world economic activity, trade liberalization and current growth in Asian economies is the main driving cause in global marine industry. In the upcoming years, the industry is projected to get benefit from improving trade levels with greater demand from the logistics and shipping sectors. Trade between Asian countries and the rest of the world is expected t …
- がん用の稀用薬パイプライン分析A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being de …
- Unipetrol, a.s.：石油・ガスバリューチェーン分析レポート2013Unipetrol, a.s. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Unipetrol, a.s." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Unipetrol, a.s.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the compan …
- 血管造影装置の世界市場2017-2021About Angiography Devices Coronary artery disease (CAD), a type of cardiovascular disease, is one of the leading causes of deaths worldwide, which is accounting for high number of heart attacks, stroke, and death. The formation of plaque in the blood vessels can cause CAD. The disease causes narrowing of the blood vessels, which interrupts normal blood flow and may lead to ischemic stroke. For tre …
- 重要インフラ保護ソリューションの世界市場：ネットワークセキュリティ、物理セキュリティ、レーダー、CBRNE、車両識別管理、セキュア通信Rise in the development of automation and ICT dependency, across the verticals, the need for ensuring cost effective solutions from cyber threats/attacks is driving the critical infrastructure protection market. Critical infrastructure security solutions ensure cost efficiency and reliability as they deploy both traditional physical security and the modern cyber security. Currently the focus of th …
- 急性呼吸不全症候群：治療薬のグローバル治験動向（2014年下半期）Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Acute Respiratory Distress Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Respiratory Distress Syndro …
- ビデオゲームの世界市場2019-2023About this market The rising penetration of smartphones and improving Internet access is one of the key factors expected to trigger the market’s growth in the forthcoming years. Mobile gaming is the largest segment of the global video game market and will grow significantly during the forecast period. The continuously increasing availability of low-cost smartphones will further contribute to the g …
- 産業用車両の世界市場予測（～2021年）：フォークリフト、けん引車、アイルトラック、コンテナ・ハンドラー、無人搬送車（AGV）The industrial vehicles market, in terms of value, is projected to grow at a CAGR of 1.86% from 2016 to 2021. The market is estimated to be USD 13.45 Billion in 2016, and is projected to reach 14.75 Billion by 2021. The increased industrialization and setting up of warehouses to support hub and spoke model for various sectors are expected to drive the industrial vehicles market. The industrial veh …
